These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 9316026

  • 1. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus).
    Taylor JR, Elsworth JD, Roth RH, Sladek JR, Redmond DE.
    Neuroscience; 1997 Dec; 81(3):745-55. PubMed ID: 9316026
    [Abstract] [Full Text] [Related]

  • 2. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
    Elsworth JD, Taylor JR, Sladek JR, Collier TJ, Redmond DE, Roth RH.
    Neuroscience; 2000 Dec; 95(2):399-408. PubMed ID: 10658619
    [Abstract] [Full Text] [Related]

  • 3. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls.
    Taylor JR, Elsworth JD, Roth RH, Sladek JR, Collier TJ, Redmond DE.
    Exp Brain Res; 1991 Dec; 85(2):335-48. PubMed ID: 1893983
    [Abstract] [Full Text] [Related]

  • 4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A, Sautter J, Schwarz J, Riederer P, Gerlach M, Oertel WH.
    Brain Res; 1996 Nov 25; 741(1-2):185-96. PubMed ID: 9001722
    [Abstract] [Full Text] [Related]

  • 5. Expression of striatal preprotachykinin mRNA in symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys is related to parkinsonian motor signs.
    Wade TV, Schneider JS.
    J Neurosci; 2001 Jul 01; 21(13):4901-7. PubMed ID: 11425917
    [Abstract] [Full Text] [Related]

  • 6. Developing a stable bilateral model of parkinsonism in rhesus monkeys.
    Smith RD, Zhang Z, Kurlan R, McDermott M, Gash DM.
    Neuroscience; 1993 Jan 01; 52(1):7-16. PubMed ID: 8433810
    [Abstract] [Full Text] [Related]

  • 7. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease.
    Goldberg JA, Boraud T, Maraton S, Haber SN, Vaadia E, Bergman H.
    J Neurosci; 2002 Jun 01; 22(11):4639-53. PubMed ID: 12040070
    [Abstract] [Full Text] [Related]

  • 8. Physiology of MPTP tremor.
    Bergman H, Raz A, Feingold A, Nini A, Nelken I, Hansel D, Ben-Pazi H, Reches A.
    Mov Disord; 1998 Jun 01; 13 Suppl 3():29-34. PubMed ID: 9827591
    [Abstract] [Full Text] [Related]

  • 9. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.
    Albanese A, Granata R, Gregori B, Piccardi MP, Colosimo C, Tonali P.
    Neuroscience; 1993 Aug 01; 55(3):823-32. PubMed ID: 8105418
    [Abstract] [Full Text] [Related]

  • 10. A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey.
    Bezard E, Imbert C, Deloire X, Bioulac B, Gross CE.
    Brain Res; 1997 Aug 22; 766(1-2):107-12. PubMed ID: 9359593
    [Abstract] [Full Text] [Related]

  • 11. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Doudet D, Gross C, Lebrun-Grandié P, Bioulac B.
    C R Seances Soc Biol Fil; 1985 Aug 22; 179(1):85-97. PubMed ID: 3161601
    [Abstract] [Full Text] [Related]

  • 12. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.
    Bergman H, Wichmann T, Karmon B, DeLong MR.
    J Neurophysiol; 1994 Aug 22; 72(2):507-20. PubMed ID: 7983515
    [Abstract] [Full Text] [Related]

  • 13. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
    Lange KW.
    Fortschr Neurol Psychiatr; 1989 Apr 22; 57(4):142-8. PubMed ID: 2656447
    [Abstract] [Full Text] [Related]

  • 14. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 Apr 22; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 15. Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier.
    Taylor JR, Roth RH, Sladek JR, Redmond DE.
    Behav Neurosci; 1990 Aug 22; 104(4):564-76. PubMed ID: 2206426
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study.
    Elsworth JD, Brittan MS, Taylor JR, Sladek JR, Redmond DE, Innis RB, Zea-Ponce Y, Roth RH.
    Brain Res; 1998 Jun 08; 795(1-2):55-62. PubMed ID: 9622593
    [Abstract] [Full Text] [Related]

  • 17. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions.
    Elsworth JD, Deutch AY, Redmond DE, Taylor JR, Sladek JR, Roth RH.
    Neuroscience; 1989 Jun 08; 33(2):323-31. PubMed ID: 2622529
    [Abstract] [Full Text] [Related]

  • 18. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K, Kondo T, Narabayashi H.
    No To Shinkei; 1987 Jul 08; 39(7):663-72. PubMed ID: 3314916
    [Abstract] [Full Text] [Related]

  • 19. Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Tetrud JW, Langston JW, Garbe PL, Ruttenber AJ.
    Neurology; 1989 Nov 08; 39(11):1483-7. PubMed ID: 2812327
    [Abstract] [Full Text] [Related]

  • 20. Subthalamotomy improves MPTP-induced parkinsonism in monkeys.
    Guridi J, Herrero MT, Luquin R, Guillen J, Obeso JA.
    Stereotact Funct Neurosurg; 1994 Nov 08; 62(1-4):98-102. PubMed ID: 7631095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.